Analysis of Oral Hypoglycemic Drugs Used in Our Hospital from 2006 to 2008

OBJECTIVE To evaluate the use of oral hypoglycemic drugs in our hospital in order to provide an reference for rational use of drugs in clinic. METHODS DDDs, sales volume, and daily expenses of drugs in our hospital from 2006 to 2008 were analyzed with the method of DDD analysis. RESULTS DDDs of oral hypoglycemic drugs (Metformin, Repaglinide, Acarbose, Glimepiride, Gliclazide Modified Release, Rosiglitazone Sodium) increased year by year, sales volumes increased slightly. The top 3 oral hypoglycemic drugs in respect of DDDs were Metformin, Repaglinide, Acarbose; The top 3 oral hypoglycemic drugs in respect of sales volume were Repaglinide, Metformin, Acarbose. The ratio of sales volume sequencing to that of DDDs was between 0.5-2.2. CONCLUSION Metformin, Repaglinide, Acarbose were most used in our hospital, especially the new hypoglycemic drugs were widely used. The use of oral hypoglycemic drugs in our hospital is rational in the main.